Myocardial infarction (heart attack) is damage to the heart muscle due to blockage of the coronary arteries that supply the area. Mild to moderate heart muscle damage can be reduced by using percutaneous coronary intervention (PCI), namely installing a ring or coronary artery bypass surgery (CABG) or what is usually called a bypass.
However, heart muscle that has been damaged cannot heal on its own, and large and severe areas of infarction can cause heart failure. Until now, the procedure to treat heart failure is a heart transplant from a donor or an iron heart/ventricular assist device (VAD), which takes a lot of time and money, and the chance of a suitable heart is only 4.7%. Therefore, the need to look for alternatives to transplantation and VAD to treat heart failure is very necessary.
Our therapy focuses on regeneration methods by repairing damaged heart walls with biological matrix and cell therapy so that it can stimulate the growth of heart muscle tissue back to normal. This method aims is to restore heart function and improve the patient’s quality of life after a heart attack or myocardial infarction.